Contact
Please use this form to send email to PR contact of this press release:
BeiGene Announces Acceptance of Supplemental Import Drug Application in China for ABRAXANE® in Metastatic Pancreatic Cancer
TO:
Please use this form to send email to PR contact of this press release:
BeiGene Announces Acceptance of Supplemental Import Drug Application in China for ABRAXANE® in Metastatic Pancreatic Cancer
TO: